UNITY Biotechnology Reports Granting of New Employment Inducement Award

UBX 01.07.2025

Full Press ReleaseSEC FilingsOur UBX Tweets

About Gravity Analytica

Recent News

  • 01.10.2025 - Daniil Gataulin
  • 01.07.2025 - UNITY Biotechnology Reports Granting of New Employment Inducement Award
  • 01.06.2025 - UNITY Biotechnology Announces Appointment of Federico Grossi, M.D., Ph.D., as Chief Medical Officer

Recent Filings

  • 01.23.2025 - 4 Statement of changes in beneficial ownership of securities
  • 01.07.2025 - 3 Initial statement of beneficial ownership of securities

SOUTH SAN FRANCISCO, Calif.,Jan. 07, 2025(GLOBE NEWSWIRE) --UNITY Biotechnology, Inc.(“UNITY”) [NASDAQ: UBX], a biotechnology company developing therapeutics to slow, halt, or reverse diseases of aging, today announced that onJanuary 6, 2025, the Compensation Committee of the Board of Directors (the “Board”) granted a stock-based award to a new employee,Federico Grossi, UNITY’s Chief Medical Officer, covering options to purchase 150,000 shares of UNITY common stock. The stock-based award was granted pursuant to the UNITY 2020 Employment Inducement Incentive Plan, as amended, which was approved by the Board inMarch 2020to provide for grants to newly hired employees as a material inducement for them to commence employment with UNITY in accordance with Nasdaq Stock Market Rule 5635(c)(4).

About UNITYUNITY is developing a new class of therapeutics to slow, halt or reverse diseases of aging. UNITY’s current focus is on creating medicines to selectively eliminate or modulate senescent cells and thereby provide transformative benefit in age-related ophthalmologic and neurologic diseases. More information is available atwww.unitybiotechnology.comor follow us onTwitterandLinkedIn.

Media ContactInizio Evoke CommsKatherine Smithkatherine.smith@inizioevoke.com

Investor ContactLifeSci Advisors, LLCJoyce Allairejallaire@lifesciadvisors.com

Primary Logo

Source: Unity Biotechnology, Inc.

Please be aware that the following content has been generated by an AI system and may contain errors, inconsistencies, or outdated information. It is provided as-is without any warranties or guarantees of accuracy. We strongly recommend using this content as a starting point for further research and consultation with relevant experts or authorities. We disclaim any liability for damages or losses resulting from the use or reliance on this content.Please note that this is a beta version of the Gravity Analytica LLC’s AI Service which isstill undergoing final testing before its official release. Theplatform, its software and all content found on it are provided on an“as is” and “as available” basis. Gravity Analytica LLC does not give any warranties,whether express or implied, as to the suitability or usability of thisservice, webpage, or its software or any of its content.Should you encounter any bugs, glitches, lack of functionality orother problems on the website, please let us know immediately so wecan rectify these accordingly. Your help in this regard is greatlyappreciated! You can write to us at this addressteam@gravityanalytica.com